...premium quality siRNAs you need for your gene sile...ed online by providing either the 19-21 base targe...e siRNA sequences. (Also check out Ambion's Silenc...ch are already designed for you.) For your conveni...
Goat Anti-Human TGF-beta RIIb Polyclonal Antibody, Unconjugated from R&D Systems
Sheep Prolactin from Cell Sciences
Nucleon HT Genomic DNA Extraction Kit from GE Healthcare, formerly Amersham Biosciences
Biology Products:(Date:11/24/2009)... , REYKJAVIK, Iceland, November 24 /PR...aq: DCGN ) today announced that it has received no...the company,s common stock will be,suspended as of... with the,Securities and Exchange Commission, whic...n Nasdaq, unless the company files an appeal to th...
(Date:11/24/2009)... Health care employment grew by 29,00...one to show consistent growth during the U.S. rece...main in trouble, and health systems are coming clo...nstead of just administrators. , ...mployment continued growing in October despite the...
(Date:11/24/2009)... SHANGHAI, Nov. 24 /PRNewswire-Asia/ -- NOD Ph...rademark Office (PTO) has allowed the patent appli...technology. , NOD technology is a highly ...eins into bio-adhesive nano-particles to enable or...ections. NOD technology is a platform technology,t...
(Date:11/24/2009)..., SHANGHAI, Nov. 24 /PRNewswire-Asia/ -- Shan...; Drug Administration (SFDA) has approved the,inve...l insulin project,(Nodlin), an innovative insulin ...llows Biolaxy to initiate its first phase I clinic...teristic of high blood glucose and poor,metabolism...
Breaking Biology Technology:deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 4Biolaxy Secures IND Approval for Oral Insulin 2